Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves

Open Access
Publisher Website
Google Scholar
Abstract
We investigated the distribution and function of cannabinoid (CB)1receptors in the submucosal plexus of the guinea pig ileum. CB1receptors were found on both types of submucosal secretomotor neurons, colocalizing with VIP and neuropeptide Y (NPY), the noncholinergic and cholinergic secretomotor neurons, respectively. CB1receptors colocalized with transient receptor potential vanilloid-1 receptors on paravascular nerves and fibers in the submucosal plexus. In the submucosal ganglia, these nerves were preferentially localized at the periphery of the ganglia. In denervated ileal segments, CB1receptor immunoreactivity in submucosal neurons was not modified, but paravascular and intraganglionic fiber staining was absent. Short-circuit current ( Isc) was measured as an indicator of net electrogenic ion transport in Ussing chambers. In the ion-transport studies, Iscresponses to capsaicin, which activates extrinsic primary afferents, and to electrical field stimulation (EFS) were reduced by pretreatment with the muscarinic antagonist atropine, abolished by tetrodotoxin, but were unaffected by VIP receptor desensitization, hexamethonium, α-amino-3-hydroxy-5-methlisoxazole-4-proprionic acid, or N-methyl-d-aspartate glutamate receptor antagonists. The responses to capsaicin and EFS were reduced by 47 ± 12 and 30 ± 14%, respectively, by the CB1receptor agonist WIN 55,212–2. This inhibitory effect was blocked by the CB1receptor antagonist, SR 141716A. Iscresponses to forskolin or carbachol, which act directly on the epithelium, were not affected by WIN 55,212–2. The inhibitory effect of WIN 55,212–2 on EFS-evoked secretion was not observed in extrinsically denervated segments of ileum. Taken together, these data show cannabinoids act at CB1receptors on extrinsic primary afferent nerves, inhibiting the release of transmitters that act on cholinergic secretomotor pathways.